Growth factors in bone
- PMID: 10093814
- PMCID: PMC3619673
- DOI: 10.1007/s002640050290
Growth factors in bone
Abstract
Bone contains several growth factors, including bone morphogenetic proteins (BMPs), transforming growth factor beta (TGF-beta), insulin-like growth factors I and II (IGF-I and IGF-II), platelet derived growth factor (PDGF) and basic and acidic fibroblast growth factor (bFGF and aFGF). Spatial and temporal variations in the expression and secretion of the various growth factors have been demonstrated in osteoblastic cultures and in various experimental and clinical in vivo models, including fracture healing in humans. Local application of various growth factors influences proliferation, differentiation and protein synthesis in osteoblastic cultures and bone formation in different animal models, including experimental fractures and skeletal defects. The BMPs are the only growth factors known to provoke bone formation heterotopically by making undifferentiated mesenchymal cells differentiate into osteoblasts (osteoinduction). BMPs and other growth factors, soon to become commercially available for clinical use, need a delivery system for their sustained release, as the factors are otherwise rapidly absorbed. Some existing systems inhibit bone formation by inducing chronic inflammation or physically by unresorbed carrier obstructing bone formation. New delivery systems are being investigated.
L’os contient plusieurs facteurs de croissance notamment: la protéine morphogénétique osseuse (BMPs), le facteur de croissance bêta (TGF-B), les facteurs de croissance insuline-like I et II (IGF-I et IGF-II), le facteur de croissance plaquettaire (PDGF) et les facteurs de croissance fibroblastique basique et acide (bFGF et aFGF). Des variations spatiales et temporelles de la secrétion des différents facteurs de croissance ont été démontrées dans les cultures ostéoblastiques et dans différent modèle expérimental et clinique notamment, la consolidation de fracture chez l’homme. L’application locale des différents facteurs de croissance influence la prolifération, la différenciation et la synthèse protéique dans les cultures d’ostéoblastes ainsi que la formation osseuse dans les différents modèles animaux avec notamment fracture expérimentale et perte de substance squelettique. Les BMPs sont les seuls facteurs de croissance connus pour provoquer une formation d’os hétérotopique par différenciation en ostéoblastes des cellules mésenchymateuses indifférenciées (ostéoinduction). Les BMPs et les autres facteurs de croissance seront bientôt commercialement disponibles pour l’usage clinique ce qui nècessitera des systèmes de distribution particuliers pour leur préservation. Il existe déjà des systèmes inhibant la formation osseuse de façon physique ou en induisant une inflammation chronique.
Similar articles
-
Wound healing: the role of growth factors.Drugs Today (Barc). 2003 Oct;39(10):787-800. doi: 10.1358/dot.2003.39.10.799472. Drugs Today (Barc). 2003. PMID: 14668934 Review.
-
Growth factors and the skeletal system.J Endocrinol Invest. 1989 Sep;12(8):577-84. doi: 10.1007/BF03350764. J Endocrinol Invest. 1989. PMID: 2687354 Review. No abstract available.
-
The role of growth factors in the repair of bone. Biology and clinical applications.J Bone Joint Surg Am. 2002 Jun;84(6):1032-44. doi: 10.2106/00004623-200206000-00022. J Bone Joint Surg Am. 2002. PMID: 12063342 Review. No abstract available.
-
Osteoinduction by demineralised bone.Int Orthop. 1998;22(5):335-42. doi: 10.1007/s002640050273. Int Orthop. 1998. PMID: 9914941 Free PMC article. Review.
-
Osteoinductive growth factors in preclinical fracture and long bone defects models.Orthop Clin North Am. 1999 Oct;30(4):647-58. doi: 10.1016/s0030-5898(05)70117-6. Orthop Clin North Am. 1999. PMID: 10471769 Review.
Cited by
-
Gene-Activated Titanium Surfaces Promote In Vitro Osteogenesis.Int J Oral Maxillofac Implants. 2017 Mar/Apr;32(2):e83–e96. doi: 10.11607/jomi.5026. Epub 2016 Oct 5. Int J Oral Maxillofac Implants. 2017. PMID: 27706263 Free PMC article.
-
Nano-Scale Surface Modifications to Advance Current Treatment Options for Cervical Degenerative Disc Disease (CDDD).J Orthop Res Ther. 2019;4(9):1147. Epub 2019 Oct 6. J Orthop Res Ther. 2019. PMID: 33709068 Free PMC article.
-
Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone.Med Oncol. 2013;30(3):606. doi: 10.1007/s12032-013-0606-8. Epub 2013 May 21. Med Oncol. 2013. PMID: 23690270
-
Accelerated Bone Induction of Adult Rat Compact Bone Plate Scratched by Ultrasonic Scaler Using Acidic Electrolyzed Water.Materials (Basel). 2021 Jun 17;14(12):3347. doi: 10.3390/ma14123347. Materials (Basel). 2021. PMID: 34204338 Free PMC article.
-
Regulation of integrin and growth factor signaling in biomaterials for osteodifferentiation.Beilstein J Org Chem. 2015 May 13;11:773-83. doi: 10.3762/bjoc.11.87. eCollection 2015. Beilstein J Org Chem. 2015. PMID: 26124879 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
